RNAi-mediated gene knockdown and anti-angiogenic therapy of RCCs using a cyclic RGD-modified liposomal-siRNA system.
about
In Vivo Biodistribution and Anti-Tumor Efficacy Evaluation of Doxorubicin and Paclitaxel-Loaded Pluronic Micelles Decorated with c(RGDyK) PeptideNew paradigms on siRNA local application.Systemic Administration of siRNA via cRGD-containing Peptide.Hyaluronan Synthase 3 Null Mice Exhibit Decreased Intestinal Inflammation and Tissue Damage in the DSS-Induced Colitis Model.Optimization of a siRNA Carrier Modified with a pH-Sensitive Cationic Lipid and a Cyclic RGD Peptide for Efficiently Targeting Tumor Endothelial CellsScalable preparation of poly(ethylene glycol)-grafted siRNA-loaded lipid nanoparticles using a commercially available fluidic device and tangential flow filtration.A nanostructure of functional targeting epirubicin liposomes dually modified with aminophenyl glucose and cyclic pentapeptide used for brain glioblastoma treatmentRedefining the role(s) of endothelial αvβ3-integrin in angiogenesis.Anti-angiogenic nanotherapy via active targeting systems to tumors and adipose tissue vasculature.Innovative Technologies in Nanomedicines: From Passive Targeting to Active Targeting/From Controlled Pharmacokinetics to Controlled Intracellular Pharmacokinetics.Protecting liver sinusoidal endothelial cells suppresses apoptosis in acute liver damage.Does ligand-receptor mediated competitive effect or penetrating effect of iRGD peptide when co-administration with iRGD-modified SSL?Gene delivery nanoparticles to modulate angiogenesis.Engineering liposomal nanoparticles for targeted gene therapy.Combination of nanotechnology with vascular targeting agents for effective cancer therapy.Dual-targeting nanoparticles with excellent gene transfection efficiency for gene therapy of peritoneal metastasis of colorectal cancer.Remodeling of the Extracellular Matrix by Endothelial Cell-Targeting siRNA Improves the EPR-Based Delivery of 100 nm Particles.Noninvasive imaging of c(RGD)2 -9R as a potential delivery carrier for transfection of siRNA in malignant tumors.Targeting tumor microenvironment to curb chemoresistance via novel drug delivery strategies.Gelofusine Attenuates Tubulointerstitial Injury Induced by cRGD-Conjugated siRNA by Regulating the TLR3 Signaling Pathway.
P2860
Q28550452-5762F1BD-CF8A-4CA5-8439-F8367D7DA3A1Q35676356-D29FA105-65FE-486C-97B2-6099F287A0E1Q35989535-BFE97D98-1A00-45C8-BD34-B906E65C4926Q36089315-DEB2B0F3-0D05-4463-8354-51935FA46D25Q36105850-2969811A-E4D0-4047-AB87-A08DD2516020Q36269077-DDF45EE1-E97A-4D1C-8B63-35DB9C8D15D9Q36544942-DAF3EE84-426A-441F-B015-02E2A92652C2Q38268451-04B801B8-A2D3-4F7D-B568-762C1670D62DQ38564219-D43F6DF1-809F-462D-BB31-F07ADE405947Q38802167-5D89E7DB-782C-4C2C-8D0D-EA1D6926A6DAQ38826054-803967E5-A39A-4D93-9DAE-18EF76045F02Q38862473-55B673DA-FCDA-45BA-818B-DF767C0B86C3Q39027588-66E36D3E-E90A-4E9E-B3C2-70E25CD28E5EQ39306702-4106D88E-664F-4A98-A00C-447217A595F8Q39368839-1C6596EA-D477-4E69-8CD4-BB52D22FFF5DQ45874849-D07782F2-B686-4EC4-9B6B-7A708ABE5238Q46219895-0C980117-9363-4C80-8260-E41AE422645AQ48258100-F123B391-264A-4A0B-A711-8E2C5F47E057Q48308048-E44FE6A8-0BC5-43E8-A30B-052F739B0EFBQ55269808-35FD8341-1A43-4B3B-A811-C54D3F5C55D3
P2860
RNAi-mediated gene knockdown and anti-angiogenic therapy of RCCs using a cyclic RGD-modified liposomal-siRNA system.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
RNAi-mediated gene knockdown a ...... dified liposomal-siRNA system.
@en
RNAi-mediated gene knockdown a ...... dified liposomal-siRNA system.
@nl
type
label
RNAi-mediated gene knockdown a ...... dified liposomal-siRNA system.
@en
RNAi-mediated gene knockdown a ...... dified liposomal-siRNA system.
@nl
prefLabel
RNAi-mediated gene knockdown a ...... dified liposomal-siRNA system.
@en
RNAi-mediated gene knockdown a ...... dified liposomal-siRNA system.
@nl
P2093
P1476
RNAi-mediated gene knockdown a ...... dified liposomal-siRNA system.
@en
P2093
Hidetaka Akita
Hideyoshi Harashima
Kyoko Hida
Noritaka Ohga
Yu Sakurai
Yusuke Sato
P304
P356
10.1016/J.JCONREL.2013.10.003
P407
P577
2013-10-11T00:00:00Z